Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity Disorder

L. Wolraich, Mark; L. Greenhill, Laurence; E. Pelham, William; M. Swanson, James; E. Wilens, Timothy; Palumbo, Donna; S. Atkins, Marc; McBurnett, Keith; G. Bukstein, Oscar; J. August, Gerald; behalf of the Concerta Study Group, on

doi:10.1542/peds.108.4.883

Public

Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity Disorder

Published in PEDIATRICS • Oct 1, 2001

Authors:

Mark L. Wolraich

Laurence L. Greenhill

William E. Pelham

Abstract

OBJECTIVE: A new once-a-day methylphenidate (MPH) formulation, Concerta (methylphenidate HCl) extended-release tablets (OROS MPH), has been developed. This study was conducted to determine the safety and efficacy of OROS MPH in a multicenter, randomized, clinical trial. METHODS: Children with attent...

Subject

Methylphenidate

Attention deficit hyperactivity disorder

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!